Briefing: Opinion: Medicare is restricting care for 1 million Americans based on a faulty assumption. Congress must intervene
Strategic angle: Medicare is restricting care for 1 million Americans based on a faulty assumption.
Editorial Staff Apr 1
Health
Latest Health stories from Life.
Briefing: STAT+: The biotech scorecard for the second quarter: 23 stock-moving events to watch
Strategic angle: Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the second quarter.
Editorial Staff Apr 1
Briefing: Why an ovary syndrome may get a new name: Men seem to have PCOS, too
Strategic angle: A quiet effort to change the name of PCOS is nearing completion, driven in part by growing evidence of a male version.
Editorial Staff Apr 1
Briefing: STAT+: The HSA industry makes its MAHA pitch
Strategic angle: A new lobbying group tied to the health savings account industry is pushing hard to make HSAs far more widely available.
Editorial Staff Mar 31
Briefing: HHS Renames U.S. Health IT Office
Strategic angle: The Trump administration reverts the name of the federal health IT office to the Office of the National Coordinator.
Editorial Staff Mar 31
Briefing: Overview of President Trump’s Executive Actions on Global Health
Strategic angle: This guide provides an overview of executive orders and other executive actions made by the Trump Administration since January 21, 2025 that directly address or affect U.S. global health efforts.
Editorial Staff Mar 31
Briefing: How Does U.S. Life Expectancy Compare to Other Countries?
Strategic angle: This chart collection examines how life expectancy in the U.S. compares to that of other similarly large and wealthy countries.
Editorial Staff Mar 31
Briefing: Baby KJ Scientists Hit Speed Bump in Quest to Scale Custom Gene Editor
Strategic angle: The scientists who treated Baby KJ say the FDA's strict standards will make it much harder to create bespoke gene editing for others.
Editorial Staff Mar 31
Briefing: STAT+: OpenEvidence inks deal with major health system
Strategic angle: OpenEvidence partners with a significant health system to enhance health record sharing.
Editorial Staff Mar 31
Briefing: Pharma Delays Launches in Europe Amid U.S. Pressure
Strategic angle: Drugmakers are postponing the release of new medicines in Europe due to shifting pricing policies and pressures from the U.S.
Editorial Staff Mar 31
Briefing: A new survey examines mental health outcomes of gender euphoria
Strategic angle: Lead exposure and heart disease, promoting psychedelics on YouTube, and other health news from Morning Rounds
Editorial Staff Mar 31
Briefing: Psychedelic Biotechs Under Scrutiny for YouTube Promotions
Strategic angle: Biogen and Eli Lilly make takeover moves, while Doctors Without Borders criticizes Gilead amidst growing concerns in the biotech sector.
Editorial Staff Mar 31
Briefing: Whoop, maker of health and fitness tracking wristbands, valued at $10 billion after latest fundraising
Strategic angle: Whoop raised $575 million from investors including the Mayo Clinic and the sovereign wealth fund of Qatar.
Editorial Staff Mar 31
Briefing: Public Opinion on Prescription Drugs and Their Prices
Strategic angle: An in-depth look at the public's attitudes toward prescription drugs and their prices based on recent KFF poll findings.
Editorial Staff Mar 31
Briefing: Biogen to acquire immunology biotech Apellis for $5.6 billion
Strategic angle: Biogen is buying Apellis Pharmaceuticals for $5.6 billion upfront as it looks to expand its immunology business.
Editorial Staff Mar 31
Briefing: Biotech VCs Move Upstream in China's Scientific Pipelines
Strategic angle: U.S. venture capital firms are proactively investing in Chinese biotech, shifting their strategy as competition intensifies.
Editorial Staff Mar 31
Briefing: Opinion: How the next CDC director can win back America’s trust
Strategic angle: “The CDC stands at an inflection point,” write Charles J. Lockwood, Robert C. Gallo, and Sten H. Vermund.
Editorial Staff Mar 31
Briefing: Pharma giant Takeda to lay off nearly 250 workers in latest job cutting
Strategic angle: Takeda Pharmaceuticals, the largest biopharma employer in Mass., will lay off 250 workers in Cambridge beginning in July.
Editorial Staff Mar 30
Briefing: Doctors Without Borders calls Gilead ‘unconscionable’ for refusing to sell HIV prevention drug
Strategic angle: The organization criticized Gilead Sciences after months of negotiations for a limited supply of lenacapavir.
Editorial Staff Mar 30
Briefing: Why this Stanford psychiatrist thinks diet can influence serious mental health disorders
Strategic angle: Shebani Sethi is at the vanguard of metabolic psychiatry, a field that investigates the link between diet and serious mental health disorders.
Editorial Staff Mar 30